Advertisement

Noninvasive Fluxomics in Mammals by Nuclear Magnetic Resonance Spectroscopy

  • Justyna Wolak
  • Kayvan Rahimi-Keshari
  • Rex E. Jeffries
  • Maliackal Poulo Joy
  • Abigail Todd
  • Peter Pediatitakis
  • Brian J. Dewar
  • Jason H. Winnike
  • Oleg Favorov
  • Timothy C. Elston
  • Lee M. Graves
  • John Kurhanewicz
  • Daniel Vigneron
  • Ekhson Holmuhamedov
  • Jeffrey M. MacdonaldEmail author
Protocol
Part of the Methods in Pharmacology and Toxicology book series (MIPT)

Abstract

Metabolism is an interconnecting network of metabolite consumption and creation. Metabolomics has focused on metabolite concentrations in metabolic networks. Fluxomics is also required in the study of metabolism and quantifies the flux of substrate through each reaction step or a series of reaction steps (i.e., metabolic pathway or cycle), and ultimately is required for energy balance equations of the system. The primary noninvasive method of quantifying fluxes in living systems is by in vivo 13C nuclear magnetic resonance (NMR) spectroscopy. The present state of noninvasive in vivo NMR technology allows for just four simultaneous flux measurements of metabolic pathways: gluconeogenesis, glycogen synthesis, glycolysis, and citric acid cycle. Since the liver is the gatekeeper and metabolic center for the animal, in vivo fluxomics of liver is extensively reviewed. Additionally, other organ systems studies are discussed demonstrating interorgan cycles, such as the Cori and Randall cycles. This review discusses the basics of in vivo fluxomics focusing on the general details of the NMR experimental protocol and required hardware/software needed to analyze the data.

Currently, there are two general methods for determining multiple flux rates. The dynamic method entails acquiring serial time points, whereas the static method is a single measurement in which flux through metabolic pathways is quantified by isotopomer (i.e., isotope isomers) analysis. The flux data are analyzed by mathematical models to calculate the global flux measurement (in silico fluxomics), and create a mass balance of the biosystem. Models are especially useful for inferring various metabolic states of the system, which are affected by drugs, toxicants, or pathology. As with all in silico models, increasing the number of empirically derived concentrations and fluxes into the model greatly increases the accuracy and utility of the model. NMR spectroscopy (NMRS) is inherently insensitive compared to other analytical modalities, limiting the temporal resolution of the dynamic in vivo measurements. To address the NMR sensitivity, several technological advances have been made. First, magnets are now at higher magnetic field strengths. Second, the technique of dynamic nuclear polarization (DNP) of substrates increases the signal for 13C up to five orders of magnitude.

In vivo fluxomics requires a broad knowledge of biochemistry, in vivo NMRS, and metabolic modeling. Therefore, this chapter is intended as a handbook for upper division undergraduate students and graduate students in biochemistry or engineering and relates the basics of electrical and biochemical engineering and animal handling. The chapter is intended for use in an introductory graduate course on NMR-based fluxomics for physical scientist.

Key words

Fluxomics hyperpolarization in vivo NMR modeling 

Notes

Acknowledgments

Funding for the studies was provided by NIH grants GM075941-01, CA114365-01A1, P30ES10126, and RR-000046.

Glossary

Allosteric modification

Usually refers to an enzyme whose activity is modified by the presence of a ligand that binds reversibly to a site other than the active site. In the context of multisite enzyme, such allosteric effectors change the state of the enzyme to enhance or diminish substrate affinity and/or turnover number.

Cellular compartmentation

In cell biology comprise all closed parts within a cell whose lumen is usually surrounded by a single or double lipid layer membrane. Most organelles are compartments like mitochondria, chloroplasts (in photosynthetic organisms), peroxisomes, lysosomes, the endoplasmic reticulum, the cell nucleus, or the Golgi apparatus. Smaller elements like vesicles, and sometimes even microtubules can also be counted as compartments. In general, there are three main cellular compartments, they are: (1) The nuclear compartment comprising the nucleus; (2) The intercisternal space which comprises the space between the membranes of the endoplasmic reticulum (which is continuous with the nuclear envelope); and (3) The cytosol. Metabolically, the mitochondria comprise a very important compartment, even though they are by volume fraction small (from Wikipedia).

Curve fitting

Finding a curve, which matches a series of data points and possibly other constraints. This section is an introduction to both interpolation (where an exact fit to constraints is expected) and regression analysis. Both are sometimes used for extrapolation. Regression analysis allows for an approximate fit by minimizing the difference between the data points and the curve (from Wikipedia).

Dynamic flux measurement method

The measurement of isotope steady state being reached by a time series measure. In the context of this chapter, it is the serial measurement of an NMR-observable tracer, such as 13C, 15N, 19F, 3H, or 2H, and its incorporation into a metabolite.

Dynamic nuclear polarization (DNP)

Transfer of polarization from electrons to nuclei, which occurs in a magnetic field, close to absolute zero. This is done by inducing transitions, via oscillating microwave RF pulses, between the allowed energy states of the electrons and nuclei, thus transferring polarization from the electrons to the nuclei. This results in more nuclei aligned with the magnetic field, thus resulting in enhancements of the signal-to-noise on the order of several magnitudes.

Flux

The net rate or the difference between the (unidirectional) rates of the forward and reverse reactions.

Helmholtz NMR coil

A volume coil design for an NMR radiofrequency probe consisting of two connecting loops spanning 120° and separated by 60°.

In vivo fluxomics

The measuring of multiple fluxes in live biosystems using noninvasive analytical instrumentation.

Isotope tracer

Use of isotopically labeled compounds administered at levels that do not affect steady state and can be used to trace flow of atoms through reaction networks.

Isotopic balance

The distribution of a single or multiple isotopes within metabolites of a biosystem.

Mass balance

An application of conservation of mass to the analysis of physical systems. By accounting for material entering and leaving a system, mass flows can be identified. The exact conservation law used in the analysis of the system depends on the context of the problem, but all revolve around mass conservation, i.e., that matter cannot disappear or be created spontaneously (from Wikipedia).

Metabolic control analysis

A method for modeling metabolism in which equations are used to describe metabolite concentration and flux, signaling pathways, and genetic pathways.

Metabolic flux analysis (MFA)

An analysis where metabolites are measured such that the amount of metabolite formation can be measured over a given period of time. This allows for the calculation of the rate of formation, or flux, of a metabolite.

Multiple component curve-fit

The mathematical curve fitting of residuals in a time series dataset whereby the various components represent time constants for multiple rates. In the context of this chapter, this relates to metabolite turnover rate within the biosystem.

Net flux

Net flux is sometimes used to define the total flux through a metabolic pathway as some of the individual fluxes can be in reverse of the net flux direction for the entire metabolic pathway.

Non-Steady State Nonallosteric modification

This is usually a description of covalent modification of proteins (cf. posttranslational modification) such as phosphorylation that changes the properties of the target protein, e.g., recognition in signal transduction pathways or in chromatin remodeling.

Pool

Like a compartment, a pool is completely defined by the model describing the system. A pool can contain all the members of a particular chemical species for instance, even if they are in several different compartments. A pool can also describe those molecules in a particular physical environment, such as pyruvate in plasma, mitochondria, or cytosol. It can also be a purely theoretical physical space; when a tracer is infused into the bloodstream of an intact animal, the volume of its initial distribution (in plasma, intracellular space, etc.) is thought to describe its pool of entry (20).

Pseudosteady state

A situation in which all state variables remain effectively constant, at least on the macroscopic scale (from Wikipedia).

Quality factor

A dimensionless parameter describing the efficiency of a transceiver, and in context to this chapter, specifically the efficiency of an NMR radiofrequency probe and a measure of the amount of power transmitted to the amount received.

Rate

Speed of a reaction under specified conditions. For simple chemical kinetics, the rate is the first derivative of the product concentration with respect to time, dp/dt, and is equal to a rate constant multiplied by reactant concentrations.

Rate constant

Rate is the product of a rate constant and concentration (strictly, activity). Thus, the units of a rate constant depend on the order of the reaction. For a first order reaction, the rate is v = k 1 a, and the first order rate const k 1 has dimensions in seconds. For a second order reaction, v = ka.b and k has dimensions in M/s. Enzymes saturated with substrate show zero order kinetics with respect to the substrate, v = V m.

Redox state

Redox (shorthand for reduction/oxidation reaction) describes all chemical reactions in which atoms have their oxidation number (oxidation state) changed (from Wikipedia).

Signal-to-noise ratio

The ratio of signal peak to the average noise factor. Specifically, the ratio of NMR peak heights of peaks from measurable compounds to noise peaks. To improve the signal-to-noise ratio by a factor of 2, one must acquire a factor of 4 more transients.

Single component curve-fit

The mathematical curve fitting of residuals in a time series dataset whereby a single component represents a time constant for a rate. In the context of this chapter, this relates to metabolite turnover rate within the biosystem.

Solenoid NMR coil

A volume coil design for an NMR radiofrequency probe consisting a wound wire or coil, like a spring, whereby the optimum spacing f loops is equal to the wire diameter.

Static flux measurement method

A method of flux analysis whereby 13C fractional enrichment or isotopomers are quantified in a single sample at steady state.

Steady state

A situation in which all state variables are constant in spite of ongoing processes that strive to change them. For an entire system to be at steady state, i.e., for all state variables of a system to be constant, there must be a flow through the system (compare mass balance) (from Wikipedia).

Volume of distribution

A value used to describe the distribution of a xenobiotic between blood plasma and the rest of the body. Xenobiotics with higher volumes of distribution are generally lipid-soluble and thus have low blood plasma concentrations after dosing. Those with lower volumes of distribution are generally more polar and thus have high blood plasma concentrations after dosing.

References

  1. 1.
    Murray RK, Granner DK, Rodwell VW, editors. Harper’s illustrated biochemistry, 27th ed. New York: The McGraw-Hill Companies Inc.; 2006.Google Scholar
  2. 2.
    Nelson DL, Cox MM, editors. Lehninger principles of biochemistry, vol. 4. 4th ed. New York: W.H. Freeman & Company; 2004.Google Scholar
  3. 3.
    Wegener G, Krause U. Different modes of activating phosphofrustokinase, a key regulatory enzyme of glycolysis, in working vertebrate muscle. Biochem Soc Trans. 2002;30(2):264–70.PubMedGoogle Scholar
  4. 4.
    Hunsucker SA, Mitchell BS, Spychala J. The 5′-nucleotidases as regulators of nucleotide and drug metabolism. Pharmacol Ther. 2005;107(1):1–30.PubMedGoogle Scholar
  5. 5.
    Huang M, Graves LM. De novo synthesis of pyrimidine nucleotides; emerging interfaces with signal transduction pathways. Cell Mol Life Sci. 2003;60(2):321–36.PubMedGoogle Scholar
  6. 6.
    Mathews CK. DNA precursor metabolism and genomic stability. FASEB J. 2006;20(9):1300–14.PubMedGoogle Scholar
  7. 7.
    Yeung M, Thiele I, Palsson BO. Estimation of the number of extreme pathways for metabolic networks. BMC Bioinformatics. 2007;8(1):363.PubMedCentralPubMedGoogle Scholar
  8. 8.
    Vo TD, Palsson BO. Isotopomer analysis of myocardial substrate metabolism: a systems biology approach. Biotechnol Bioeng. 2006;95(5):972–83.PubMedGoogle Scholar
  9. 9.
    Lee DY, Yun H, Park S, Lee SY. MetaFluxNet: the management of metabolic reaction information and quantitative metabolic flux analysis. Bioinformatics. 2003;19:2144–6.PubMedGoogle Scholar
  10. 10.
    Wiechert W, Schweissgut O, Takanaga H, Frommer WB. Fluxomics: mass spectrometry versus quantitative imaging. Curr Opin Plant Biol. 2007;10(3):323–30.PubMedCentralPubMedGoogle Scholar
  11. 11.
    Droste P, Weitzel M, Wiechert W. Visual exploration of isotope labeling networks in 3D. Bioprocess Biosyst Eng. 2008;31(3):227–39.PubMedGoogle Scholar
  12. 12.
    Massou S, Nicolas C, Letisse F, Portais JC. NMR-based fluxomics: quantitative 2D NMR methods for isotopomers analysis. Phytochemistry. 2007;68(16–18):2330–40.PubMedGoogle Scholar
  13. 13.
    Ataullakhanov FI, Vitvitsky VM. What determines the intracellular ATP concentration. Biosci Rep. 2002;22(5–6):501–11.PubMedGoogle Scholar
  14. 14.
    Diaz J, Hetzer G, Tello L. An energy balance climate model with hysteresis. Nonlinear Anal. 2006;64(9):2053–74.Google Scholar
  15. 15.
    Hatzianastassiou N, Fotiadi A, Matsoukas C, Pavlakis KG, Drakakis E, Hatzidimitriou D, Vardavas I. Long-term global distribution of Earth’s shortwave radiation budget at the top of atmosphere. Atmos Chem Phys. 2004;4:1217–35.Google Scholar
  16. 16.
    Cai M. Dynamical amplification of polar warming. Geophys Res Lett. 2005;32(22):22710.Google Scholar
  17. 17.
    Warburg O, Wind F, Negelein E. The metabolism of turmos in the body. J Gen Physiol. 1927;3:519–30.Google Scholar
  18. 18.
    Gruetter R, Magnusson I, Rothman DL, Avison MJ, Shulman RG, Shulman GI. Validation of 13C NMR measurements of liver glycogen in vivo. Magn Reson Med. 1994;31(6):583–8.PubMedGoogle Scholar
  19. 19.
    Lee K, Berthiaume F, Stephanopoulos GN, Yarmush DM, Yarmush ML. Metabolic flux analysis of postburn hepatic hypermetabolism. Metab Eng. 2000;2(4):312–27.PubMedGoogle Scholar
  20. 20.
    Laughlin MR, Kelleher JK. Tracer theory and 13C NMR. In: Berliner LJ, Robitaille P-M, editors. Biological magnetic resonance: in vivo carbon-13 NMR. New York: Kluwer Academic Publishers; 2002.Google Scholar
  21. 21.
    Sherry AD, Malloy CR. Biological magnetic resonance: in vivo carbon-13 NMR: 13C isotopomer analysis of glutamate. A NMR method to probe metabolic pathways intersecting in the citric acid cycle. In: Berliner LJ, Robitaille PM, editors. Biological magnetic resonance: in vivo carbon-13 NMR. New York: Kluwer Academic Publishers; 2002.Google Scholar
  22. 22.
    Geissler A, Kanamori K, Ross BD. Real-time study of the urea cycle using 15N NMR in the isolated perfused rat liver. Biochem J. 1992;287:813–20.PubMedGoogle Scholar
  23. 23.
    Grunder W, Krumbiegel P, Gersonde K. 15N NMR of glycine metabolism in liver, muscle, and kidney using a new pulsed overhauser technique (POE). Isotopenpraxis Isot Environ Health Stud. 1992;28:81–4.Google Scholar
  24. 24.
    Gabel SA, London RE. A deuterium surface coil nmr study of the metabolism of D-methionine in the liver of the anesthetized rat. Biochemistry. 1988;27(20):7864–9.PubMedGoogle Scholar
  25. 25.
    Nissim I, Lapidot A. Plasma amino acid turnover rates and pools in rabbits: in vivo studies using stable isotopes. Am J Physiol. 1979;237(5):E418–27.PubMedGoogle Scholar
  26. 26.
    Wagenmakers AJ. Tracers to investigate protein and amino acid metabolism in human subjects. Proc Nutr Soc. 1999;58(4):987–1000.PubMedGoogle Scholar
  27. 27.
    Guillet C, Boirie Y, Walrand S. An integrative approach to in-vivo protein synthesis measurement: from whole tissue to specific proteins. Curr Opin Clin Nutr Metab Care. 2004;7(5):531–8.PubMedGoogle Scholar
  28. 28.
    Zawalich WS. Modulation of insulin secretion from beta-cells by phosphoinositide-derived second-messenger molecules. Diabetes. 1988;37(2):137–41.PubMedGoogle Scholar
  29. 29.
    Lodish H, Berk A, Zipursky SL, Matsudaira P, Baltimore D, Darnell J. Molecular cell biology. New York: W.H. Freeman & Company; 1999.Google Scholar
  30. 30.
    Jahoor F, Burrin DG, Reeds PJ, Frazer M. Measurement of plasma protein synthesis rate in infant pig: an investigation of alternative tracer approaches. Am J Physiol. 1994;267(1 Pt 2):R221–7.PubMedGoogle Scholar
  31. 31.
    Berthold HK, Jahoor F, Klein PD, Reeds PJ. Estimates of the effect of feeding on whole-body protein degradation in women vary with the amino acid used as tracer. J Nutr. 1995;125(10):2516–27.PubMedGoogle Scholar
  32. 32.
    Morell P, Ousley AH. Metabolic turnover of myelin glycerophospholipids. Neurochem Res. 1994;19(8):967–74.PubMedGoogle Scholar
  33. 33.
    Rapoport SI. In vivo approaches and rationale for quantifying kinetics and imaging brain lipid metabolic pathways. Prostaglandins Other Lipid Mediat. 2005;77(1–4):185–96.PubMedGoogle Scholar
  34. 34.
    Ritz P, Coward WA. Doubly labelled water measurement of total energy expenditure. Diabete Metab. 1995;21(4):241–51.PubMedGoogle Scholar
  35. 35.
    Damjanovich S, Nagy I, Somogyi B. Application of a molecular enzyme kinetic model for aging cells and tissues. Arch Gerontol Geriatr. 1989;8(1):37–45.PubMedGoogle Scholar
  36. 36.
    Finch CE, Morgan DG. RNA and protein metabolism in the aging brain. Annu Rev Neurosci. 1990;13:75–88.PubMedGoogle Scholar
  37. 37.
    Grimble GK, Malik SB, Boza JJ. Methods for measuring tissue RNA turnover. Curr Opin Clin Nutr Metab Care. 2000;3(5):399–408.PubMedGoogle Scholar
  38. 38.
    Preston CC, Oberlin AS, Holmuhamedov EL, Gupta A, Sagar S, Syed RH, Siddiqui SA, Raghavakaimal S, Terzic A, Jahangir A. Aging-induced alterations in gene transcripts and functional activity of mitochondrial oxidative phosphorylation complexes in the heart. Mech Ageing Dev. 2008;129(6):304–12.PubMedCentralPubMedGoogle Scholar
  39. 39.
    White RJ. RNA polymerases I and III, growth control and cancer. Nat Rev Mol Cell Biol. 2005;6(1):69–78.PubMedGoogle Scholar
  40. 40.
    Kurhanewicz J, Bok R, Nelson SJ, Vigneron DB. Current and potential applications of clinical 13C MR spectroscopy. J Nucl Med. 2008;49(3):341–4.PubMedCentralPubMedGoogle Scholar
  41. 41.
    Gadian DG, editor. NMR and its applications to living systems. New York: Oxford University Press; 1995.Google Scholar
  42. 42.
    Mashimo K, Ohno Y. Ethanol hyperpolarizes mitochondrial membrane potential and increases mitochondrial fraction in cultured mouse myocardial cells. Arch Toxicol. 2006;80:421–8.PubMedGoogle Scholar
  43. 43.
    Thurman RG, Kauffman FC, Ji S, Lemasters JJ, Conway JG, Belinsky SA, Kashiwagi T, Matsamura T. Metabolic heterogeneity in the perfused rat liver. Pharmacol Biochem Behav. 1983;18 Suppl 1:415–9.PubMedGoogle Scholar
  44. 44.
    Testa C, Schiavina R, Lodi R, Salizzoni E, Corti B, Farsad M, Kurhanewicz J, Manferrari F, Brunocilla E, Tonon C, Monetti N, Castellucci P, Fanti S, Coe M, Grigioni WF, Martorana G, Canini R, Barbiroli B. Prostate cancer: sextant localization with MR imaging, MR spectroscopy, and 11C-choline PET/CT. Radiology. 2007;244(3):797–806.PubMedGoogle Scholar
  45. 45.
    Macdonald JM, Schmidlin O, James TL. In vivo monitoring of hepatic glutathione in anesthetized rats by 13C NMR. Magn Reson Med. 2002;48(3):430–9.PubMedGoogle Scholar
  46. 46.
    Robbins E. Radiation risks from imaging studies in children with cancer. Pediatr Blood Cancer. 2008;51(4):453–7.PubMedGoogle Scholar
  47. 47.
    Isambert A, Bonniaud G, Lavielle F, Malandain G, Lefkopoulos D. A phantom study of the accuracy of CT, MR and PET image registrations with a block matching-based algorithm. Cancer Radiother. 2008;12(8):800808.Google Scholar
  48. 48.
    Pichler BJ, Wehrl HF, Judenhofer MS. Latest advances in molecular imaging instrumentation. J Nucl Med. 2008;49 Suppl 2:5S–23.PubMedGoogle Scholar
  49. 49.
    Ikoma Y, Watabe H, Shidahara M, Naganawa M, Kimura Y. PET kinetic analysis: error consideration of quantitative analysis in dynamic studies. Ann Nucl Med. 2008;22(1):1–11.PubMedGoogle Scholar
  50. 50.
    Day SE, Kettunen MI, Gallagher FA, Hu DE, Lerche M, Wolber J, Golman K, Ardenkjaer-Larsen JH, Brindle KM. Detecting tumor response to treatment using hyperpolarized 13C magnetic resonance imaging and spectroscopy. Nat Med. 2007;13(11):1382–7.PubMedGoogle Scholar
  51. 51.
    Szyperski T. 13C-NMR MS and metabolic flux balancing in biotechnology research. Q Rev Biophys. 1998;31(1):41–106.PubMedGoogle Scholar
  52. 52.
    London RE. Carbon-13 labeling in studies of metabolic regulation. Prog Nucl Magn Reson Spectrosc. 1988;20:337–83.Google Scholar
  53. 53.
    Stephanopoulos G, Aristidou A, Nielsen J. Metabolic engineering. San Diego: Academic; 1998.Google Scholar
  54. 54.
    Walker TE, Han CH, Kollman VH, London RE, Matwiyoff NA. 13C nuclear magnetic resonance studies of the biosynthesis by microbacterium ammoniaphilum of L-glutamate selectively enriched with carbon-13. J Biol Chem. 1982;257:1189–95.PubMedGoogle Scholar
  55. 55.
    Beylot M, David MV, Landau BR, Brunengraber H. Tracing hepatic gluconeogenesis relative to citric acid cycle activity in vitro and in vivo. comparisons in the use of [3-13C] lactate, [2-13C] acetate, and α-keto[3-13C] isocaproate. J Biol Chem. 1995;270:1509–14.PubMedGoogle Scholar
  56. 56.
    Jones JG, Le TH, Storey CJ, Sherry RA, Malloy CR, Burton KP. Effects of different oxidative insults on intermediary metabolism in isolated perfused rat hearts. Free Radic Biol Med. 1996;20:515–23.PubMedGoogle Scholar
  57. 57.
    Jones JG, Sherry RA, Malloy CR. Quantitation of gluconeogenesis by 2H nuclear magnetic resonance analysis of plasma glucose following ingestion of 2H2O. Anal Biochem. 2000;277:121–6.PubMedGoogle Scholar
  58. 58.
    Jones JG, Solomon MA, Sherry RA, Jeffrey FM, Malloy CR. 13C NMR measurements of human gluconeogenic fluxes after ingestion of [U-13C] propionate, phenylacetate, and acetaminiophen. Am J Physiol Endocrinol Metab. 1998;275:843–52.Google Scholar
  59. 59.
    Magnusson I, Chandramouli V, Schumann WC, Kumaran K, Wahren J, Landau BR. Pentose pathway in human liver. Proc Natl Acad Sci. 1988;85:4682–5.PubMedGoogle Scholar
  60. 60.
    Magnusson I, Schumann WC, Bartsch GE, Chandramouli V, Kumaran K, Wahren J, Landau BR. Noninvasive tracing of Krebs cycle metabolism in liver. J Biol Chem. 1991;266:6975–84.PubMedGoogle Scholar
  61. 61.
    Mancuso A, Sharfstein ST, Fernandez EJ, Clark DS, Blanch HW. Effect of extracellular glutamine concentration on primary and secondary metabolism of a murine hybridoma: an in vivo 13C nuclear magnetic resonance study. Biotechnol Bioeng. 1998;57:172–86.PubMedGoogle Scholar
  62. 62.
    Shulman GI, Rothman DL, Smith D, Johnson CM, Blair JB, Shulman RG, et al. Mechanism of liver glycogen repletion in vivo by nuclear magnetic resonance spectroscopy. J Clin Invest. 1985;76(3):1229–36.PubMedCentralPubMedGoogle Scholar
  63. 63.
    Ugurbil K, Brown TR, Hollander JAD, Glynn P, Shulman RG. High-resolution 13C nuclear magnetic resonance studies of glucose metabolism in Escherichia coli. Proc Natl Acad Sci U S A. 1978;75(8):3742–6.PubMedCentralPubMedGoogle Scholar
  64. 64.
    Sato K, Kashiwaya Y, Keon CA, Tsuchiya N, King MT, Radda GK, Chance B, Clarke K, Veech RL. Insulin, ketone bodies, and mitochondrial energy transduction. FASEB J. 1995;9(8):651–8.PubMedGoogle Scholar
  65. 65.
    Mayevsky A, Nioka S, Chance B. Fiber optic surface fluorometry/reflectometry and 31-p-NMR for monitoring the intracellular energy state in vivo. Adv Exp Med Biol. 1988;222:365–74.PubMedGoogle Scholar
  66. 66.
    Unkefer CJ, London RE. In vivo studies of pyridine nucleotide metabolism in Escherichia coli and Saccharomyces cerevisiae by carbon-13 NMR spectroscopy. J Biol Chem. 1984;259(4):2311–20.PubMedGoogle Scholar
  67. 67.
    Chung Y, Jue T. 1H NMR observation of redox potential in liver. Biochemistry. 1992;31(45):11159–65.PubMedGoogle Scholar
  68. 68.
    Willis JA, Schleich T. Oxidative-stress induced protein glutathione mixed-disulfide formation in the ocular lens. Biochim Biophys Acta. 1996;1313(1):20–8.PubMedGoogle Scholar
  69. 69.
    Kreutzer U, Jue T. 1H-nuclear magnetic resonance deoxymyoglobin signal as indicator of intracellular oxygenation in myocardium. Am J Physiol. 1991;261(6 Pt 2):H2091–7.PubMedGoogle Scholar
  70. 70.
    Tran TK, Kreutzer U, Jue T. Observing the deoxy myoglobin and hemoglobin signals from rat myocardium in situ. FEBS Lett. 1998;434(3):309–12.PubMedGoogle Scholar
  71. 71.
    Seagle C, Christie MA, Winnike JH, McClelland RE, Ludlow JW, O’Connell TM, Gamcsik MP, Macdonald JM. High-throughput nuclear magnetic resonance metabolomic footprinting for tissue engineering. Tissue Eng Part C Methods. 2008;14(2):107–18.PubMedGoogle Scholar
  72. 72.
    Todd A. Inclusion of a glycogen regulation mathematical model into a contextual metabolic framework. In: Applied mathematics. Chapel Hill: University of North Carolina; 2007. p. 193.Google Scholar
  73. 73.
    Sherry AD, Malloy CR. Isotopic methods for probing organization of cellular metabolism. Cell Biochem Funct. 1996;14:259–68.PubMedGoogle Scholar
  74. 74.
    Ratcliffe RG, Shachar-Hill Y. Measuring multiple fluxes through plant metabolic networks. Plant J. 2006;45:490–511.PubMedGoogle Scholar
  75. 75.
    Jones JG, Sherry D, Jeffrey FMH, Cottam GL, Malloy CR. Methods for determining gluconeogenesis, anaplerosis, and pyruvate recycling. Patent US6,329,208 B1; 2001.Google Scholar
  76. 76.
    Cohen SM. Simultaneous 13C and 31P NMR studies of perfused rat liver. Effects of insulin and glucagon and a 13C NMR assay of free Mg2+. J Biol Chem. 1983;258(23):14294–308.PubMedGoogle Scholar
  77. 77.
    Chatham JC, Forder JR. Metabolic compartmentation of lactate in the glucose-perfused rat heart. Am J Physiol. 1996;270(1 Pt 2):H224–9.PubMedGoogle Scholar
  78. 78.
    Chatham JC, Forder JR, Glickson JD, Chance EM. Calculation of absolute metabolic flux and the elucidation of the pathways of glutamate labeling in perfused rat heart by 13C NMR spectroscopy and nonlinear least squares analysis. J Biol Chem. 1995;270(14):7999–8008.PubMedGoogle Scholar
  79. 79.
    Sandström J. Dynamic N.M.R. spectroscopy. London: Academic; 1982. p. 1226.Google Scholar
  80. 80.
    Cohen SM, Shulman RG, McLaughlin AC. Effects of ethanol on alanine metabolism in perfused mouse liver studied by 13C NMR. Proc Natl Acad Sci U S A. 1979;76(10):4808–12.PubMedCentralPubMedGoogle Scholar
  81. 81.
    London RE. In vivo 2H NMR studies of cellular metabolism. In: Berliner LJ, Reuben J, editors. Biological magnetic resonance: NMR of paramagnetic molecules. New York: Kluwer Academic Publishers; 1998.Google Scholar
  82. 82.
    Thoma WJ, Ugurbil K. Saturation-transfer studies of ATP-Pi exchange in isolated perfused rat liver. Biochim Biophys Acta. 1987;893(2):225–31.PubMedGoogle Scholar
  83. 83.
    Henry PG, Adriany G, Deelchand D, Gruetter R, Marjanska M, Oz G, Seaquist ER, Shestov A, Ugurbil K. In vivo 13C NMR spectroscopy and metabolic modeling in the brain: a practical perspective. Magn Reson Imaging. 2006;24(4):527–39.PubMedGoogle Scholar
  84. 84.
    Henry PG, Tkac I, Gruetter R. 1H-localized broadband 13C NMR spectroscopy of the rat brain in vivo at 9.4 T. Magn Reson Med. 2003;50(4):684–92.PubMedGoogle Scholar
  85. 85.
    Gruetter R, Adriany G, Choi IY, Henry PG, Lei HX, Oz G. Localized in vivo 13C NMR spectoscopy of the brain. NMR Biomed. 2003;16(6–7):313–38.PubMedCentralPubMedGoogle Scholar
  86. 86.
    deGraaf RA, Mason GF, Patel AB, Behar KL, Rothman DL. In vivo 1H-[13C]-NMR spectroscopy of cerebral metabolism. NMR Biomed. 2003;313(6–7):339–57.Google Scholar
  87. 87.
    Seymour AML. Imaging cardiac metabolism in heart failure: the potential of NMR spectroscopy in the era of metabolism revisited. Heart Lung Circ. 2003;12:25–30.PubMedGoogle Scholar
  88. 88.
    Lewandowski ED. Biological magnetic resonance: in vivo carbon-13 NMR: metabolic flux and subcellular transport of metabolites. In: Berliner LJ, Robitaille PM, editors. Biological magnetic resonance: in vivo carbon-13 NMR, vol. 15. New York: Kluwer Academic Publishers; 1998.Google Scholar
  89. 89.
    Weiss RG, Gerstenblith G. Biological magnetic resonance: in vivo carbon-13 NMR. In: Berliner LJ, Robitaille PM, editors. Assessing cardiac metabolic rates during pathologic conditions with dynamic 13C NMR spectra biological magnetic resonance: in vivo carbon-13 NMR, vol. 15. New York: Kluwer Academic Publishers; 1998.Google Scholar
  90. 90.
    Borgias BA, James TL. Two-dimensional nuclear Overhauser effect: complete relaxation matrix analysis. Methods Enzymol. 1989;176:169–83.PubMedGoogle Scholar
  91. 91.
    Mendes P. Emerging bioinformatics for the metabolome. Brief Bioinform. 2002;3(2):134–45.PubMedGoogle Scholar
  92. 92.
    Macdonald JM. Toxicological applications of cell and animal models for in vivo nuclear magnetic resonance spectroscopy. San Francisco: University of California at San Francisco; 1995.Google Scholar
  93. 93.
    Silbernagl S, Volker K, Dantzler WH. Compartmentation of amino acids in the rat kidney. Am J Physiol. 1996;270(1 Pt 2):F154–63.PubMedGoogle Scholar
  94. 94.
    Alger JR, Sillerud LO, Behar KL, Gillies RJ, Shulman RG, Gordon RE, Shaw D, Hanley PE. In vivo carbon-13 nuclear magnetic resonance studies of mammals. Science. 1981;214:660–2.PubMedGoogle Scholar
  95. 95.
    Enderle JD, Blanchard SM, Bronzino JD. Introduction to biomedical engineering. Boston: Elsevier Academic Press; 2005.Google Scholar
  96. 96.
    York MJ, Kuchel PW, Chapman BE, Jones AJ. Incorporation of labelled glycine into reduced glutathione of intact human erythrocytes by enzyme-catalysed exchange. Biochem J. 1982;207:65–72.PubMedGoogle Scholar
  97. 97.
    Roser W, Beckmann N, Wiesmann U, Seelig J. Absolute quantification of the hepatic glycogen content in a patient with glycogen storage disease by 13C magnetic resonance spectroscopy. Magn Reson Imaging. 1996;14(10):1217–20.PubMedGoogle Scholar
  98. 98.
    Gruetter R, Magnusson I, Rothman DL, Avison MJ, Shulman RG, Shulman GI. Validation of 13C NMR measurements of liver glycogen in vivo. Magn Reson Med. 1994;31(6):583–8.PubMedGoogle Scholar
  99. 99.
    Murphy E, Gabel SA, Funk A, London RE. NMR observability of ATP: preferential depletion of cytosolic ATP during ischemia in perfused rat liver. Biochemistry. 1988;27(2):526–8.PubMedGoogle Scholar
  100. 100.
    Masson S, Quistorff B. The 31P NMR visibility of ATP in perfused rat liver remains about 90%, unaffected by changes of metabolic state. Biochemistry. 1992;31(33):7488–93.PubMedGoogle Scholar
  101. 101.
    Kurhanewicz J, Swanson MG, Nelson SJ, Vigneron DB. Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer. J Magn Reson Imaging. 2002;16(4):451–63.PubMedCentralPubMedGoogle Scholar
  102. 102.
    Nicholson JK, Timbrell JA, Bales JR, Sadler PJ. A high resolution proton nuclear magnetic resonance approach to the study of hepatocyte and drug metabolism. Application to acetaminophen. Mol Pharmacol. 1985;27(6):634–43.PubMedGoogle Scholar
  103. 103.
    Gamcsik MP, Millis KK, Colvin OM. Noninvasive detection of elevated glutathione levels in MCF-7 cells resistant to 4-hydroperoxycyclophosphamide. Cancer Res. 1995;55(10):2012–6.PubMedGoogle Scholar
  104. 104.
    Tian J, Yin Y, Sun H, Luo X. Magnesium chloride: an efficient 13C NMR relaxation agent for amino acids and some carboxylic acids. J Magn Reson. 2002;159(2):137–44.PubMedGoogle Scholar
  105. 105.
    London RE, Rhee CK, Murphy E, Gabel S, Levy LA. NMR-sensitive fluorinated and fluorescent intracellular calcium ion indicators with high dissociation constants. Am J Physiol. 1994;266(5 Pt 1):C1313–22.PubMedGoogle Scholar
  106. 106.
    Hoener BA, Tzika AA, Englestad BL, White DL. Hepatic transport of the magnetic resonance imaging contrast agent Fe(III)-N-(3-phenylglutaryl)desferrioxamine B. Magn Reson Med. 1991;17(2):509–15.PubMedGoogle Scholar
  107. 107.
    Chance EM, Seeholzer SH, Kobayashi K, Williamson JR. Mathematical analysis of isotope labeling in the citric acid cycle with applications to 13C NMR studies in perfused rat hearts. J Biol Chem. 1983;258(22):13785–94.PubMedGoogle Scholar
  108. 108.
    Novotny EJ, Fulbright RK, Pearl PL, Gibson KM, Rothman DL. Magnetic resonance spectroscopy of neurotransmitters in human brain. Ann Neurol. 2003;54 Suppl 6:S25–31.PubMedGoogle Scholar
  109. 109.
    Waagepetersen HS, Sonnewald U, Schousboe A. Compartmentation of glutamine, glutamate, and GABA metabolism in neurons and astrocytes: functional implications. Neuroscientist. 2003;9(5):398–403.PubMedGoogle Scholar
  110. 110.
    Shen J, Petersen KF, Behar KL, Brown P, Nixon TW, Mason GF, Petroff OA, Shulman GI, Shulman RG, Rothman DL. Determination of the rate of the glutamate/glutamine cycle in the human brain by in vivo 13C NMR. Proc Natl Acad Sci. 1999;96(14):8235–40.PubMedGoogle Scholar
  111. 111.
    Sonnewald U, Westergaard N, Hassel B, Muller TB, Unsgard G, Fonnum F, Hertz L, Schousboe A, Petersen SB. NMR spectroscopic studies of 13C acetate and 13C glucose metabolism in neocortical astrocytes: evidence for mitochnodrial heterogeneity. Dev Neurosci. 1993;15(3–5):351–8.PubMedGoogle Scholar
  112. 112.
    Melo TM, Nehlig A, Sonnewald U. Neuronal-glial interactions in rats fed a ketogenic diet. Neurochem Int. 2006;48(6–7):498–507.PubMedGoogle Scholar
  113. 113.
    Hassel B, Sonnewald U, Fonnum F. Glial-neuronal interactions as studied by cerebral metabolism of [2-13C]acetate and [1-13C]glucose: an ex vivo 13C NMR spectroscopic study. J Neurochem. 1995;64(6):2773–82.PubMedGoogle Scholar
  114. 114.
    Snell K, Walker DG. The adaptive behaviour of isoenzyme forms of rat liver alanine aminotransferases during development. Biochem J. 1972;128(2):403–13.PubMedGoogle Scholar
  115. 115.
    Pasternack LB, Laude DA, Appling DR. 13C NMR detection of folate-mediated serine and glycine synthesis in vivo in Saccharomyces cerevisiae. Biochemistry. 1992;31(37):8713–9.PubMedGoogle Scholar
  116. 116.
    Jones JG, Naidoo R, Sherry AD, Jeffrey FM, Cottam GL, Malloy CR. Measurement of gluconeogenesis and pyruvate recycling in the rat liver: a simple analysis of glucose and glutamate isotopomers during metabolism of [1,2,3-(13)C3]propionate. FEBS Lett. 1997;412(1):131–7.PubMedGoogle Scholar
  117. 117.
    Cohen SM, Rognstad R, Shulman RG, Katz J. A comparison of 13C nuclear magnetic resonance and 14C tracer studies of hepatic metabolism. J Biol Chem. 1981;256(7):3428–32.PubMedGoogle Scholar
  118. 118.
    Healing G, Smith D. Handbook of pre-clinical continuous intravenous infusion. New York: Taylor & Francis; 2000.Google Scholar
  119. 119.
    Myers R. The radio amateur’s handbook: the standard manual of amateur radio communication. Newington: The American Radio Relay League; 1995.Google Scholar
  120. 120.
    Schmidt HC, Gooding CA, James TL. In vivo 31P-MR spectroscopy of the liver in the infant rabbit to study the effect of hypoxia on the phosphorus metabolites and intracellular pH. Invest Radiol. 1986;21(2):156–61.PubMedGoogle Scholar
  121. 121.
    Wald LL, Carvajal L, Moyher SE, Nelson SJ, Grant PE, Barkovich AJ, Vigneron DB. Phased array detectors and an automated intensity-correction algorithm for high-resolution MR imaging of the human brain. Magn Reson Med. 1995;34(3):433–9.PubMedGoogle Scholar
  122. 122.
    Wald LL, Moyher SE, Day MR, Nelson SJ, Vigneron DB. Proton spectroscopic imaging of the human brain using phased array detectors. Magn Reson Med. 1995;34(3):440–5.PubMedGoogle Scholar
  123. 123.
    Benveniste H, Blackband SJ. Translational neuroscience and magnetic-resonance microscopy. Lancet Neurol. 2006;5(6):536–44.PubMedGoogle Scholar
  124. 124.
    Wright SM, Wald LL. Theory and application of array coils in MR spectroscopy. NMR Biomed. 1997;10(8):394–410.PubMedGoogle Scholar
  125. 125.
    Thelwall PE, Yemin AY, Gillian TL, Simpson NE, Kasibhatla MS, Rabbani ZN, Macdonald JM, Blackband SJ, Gamcsik MP. Noninvasive in vivo detection of glutathione metabolism in tumors. Cancer Res. 2005;65(22):10149–53.PubMedGoogle Scholar
  126. 126.
    Bottomley PA, Edelstein WA, Hart HR, Schenck JF, Smith LS. Spatial localization in 31P and 13C NMR spectroscopy in vivo using surface coils. Magn Reson Med. 1984;1(3):410–3.PubMedGoogle Scholar
  127. 127.
    Fan TW, Higashi RM. Reproducible nuclear magnetic resonance surface coil fabrication by combining computer-aided design and a photoresist process. Anal Chem. 1989;61(6):636–8.PubMedGoogle Scholar
  128. 128.
    Mulquiney PJ, Kuchel PW. Modeling metabolism with mathematica. Boca Raton: CRC Press; 2003.Google Scholar
  129. 129.
    Stephanopoulos GN, Aristidou AA, Nielsen J. Metabolic engineering: principles and methodologies. San Diego: Academic; 1998.Google Scholar
  130. 130.
    Palsson BO. Systems biology: properties of reconstructed networks. New York: Cambridge University Press; 2006.Google Scholar
  131. 131.
    Heinrich R, Schuster S. The regulation of cellular systems. New York: Chapman & Hall; 1996.Google Scholar
  132. 132.
    Fell DA. Understanding the control of metabolism. London: Portland Press; 1997.Google Scholar
  133. 133.
    Kacser H, Burns JA. The control of flux. Symp Soc Exp Biol. 1973;27:65–104 (reprinted with modern terms in: Kacser H, Burns JA, Fell DA. Biochem Soc Trans. 1995;23:341–66).Google Scholar
  134. 134.
    Heinrich R, Rapoport TA. A linear steady-state treatment of enzymatic chains. Critique of the crossover theorem and a general procedure to identify interaction sites with an effector. Eur J Biochem. 1974;42:97–105.PubMedGoogle Scholar
  135. 135.
    Heinrich R, Rapoport TA. A linear steady-state treatment of enzymatic chains. General properties, control and effector strength. Eur J Biochem. 1974;42:89–95.PubMedGoogle Scholar
  136. 136.
    Jucker BM, Barucci N, Shulman GI. Metabolic control analysis of insulin-stimulated glucose disposal in rat skeletal muscle. Am J Physiol Endocrinol Metab. 1999;277:E505–12.Google Scholar
  137. 137.
    Fell DA. MCA: a survey of its theoretical and experimental development. Biochem J. 1992;286:313–30.PubMedGoogle Scholar
  138. 138.
    Klamt S, Stelling J, Ginkel M, Gilles ED. Flux analyzer: exploring structure, pathways and flux distributions in metabolic networks on interactive flux maps. Bioinformatics. 2003;19:261–9.PubMedGoogle Scholar
  139. 139.
    Hoops S, Sahle S, Gauges R, Lee C, Pahle J, Simus N, Singhal M, Xu L, Mendes P, Kummer U. COPASI—a complex pathway simulator. Bioinformatics. 2006;22:3067–74.PubMedGoogle Scholar
  140. 140.
    Golman K, Axelsson O, Johannesson H, Mansson S, Olofsson C, Petersson JS. Parahydrogen-induced polarization in imaging: subsecond (13)C angiography. Magn Reson Med. 2001;46(1):1–5.PubMedGoogle Scholar
  141. 141.
    Goodson BM. Nuclear magnetic resonance of laser-polarized noble gases in molecules, materials, and organisms. J Magn Reson. 2002;155(2):157–216.PubMedGoogle Scholar
  142. 142.
    Golman K, Ardenkjaer-Larsen JH, Petersson JS, Mansson S, Leunbach I. Molecular imaging with endogenous substances. Proc Natl Acad Sci U S A. 2003;100(18):10435–9.PubMedCentralPubMedGoogle Scholar
  143. 143.
    Ardenkjaer-Larsen JH, Fridlund B, Gram A, Hansson G, Hansson L, Lerche MH, Servin R, Thaning M, Golman K. Increase in signal-to-noise ratio of >10,000 times in liquid-state NMR. Proc Natl Acad Sci U S A. 2003;100(18):10158–63.PubMedCentralPubMedGoogle Scholar
  144. 144.
    Bowers CR, Weitekamp DP. Parahydrogen and synthesis allow dramatically enhanced nuclear alignment. J Am Chem Soc. 1987;109:5541–2.Google Scholar
  145. 145.
    Canet D, Aroulanda C, Mutzenhardt P, Aime S, Gobetto R, Reineri F. Para-hydrogen enrichment and hyperpolarization. Concepts Magn Reson. 2006;28A(5):321–30.Google Scholar
  146. 146.
    Pravica MG, Weitekamp DP. Net NMR alignment by adiabatic transport of parahydrogen addition products to high magnetic field. Chem Phys Lett. 1998;145(4):255–8.Google Scholar
  147. 147.
    Goldman M, Johannesson H, Axelsson O, Karlsson M. Hyperpolarization of 13C through order transfer from parahydrogen: a new contrast agent for MRI. Magn Reson Imaging. 2005;23(2):153–7.PubMedGoogle Scholar
  148. 148.
    Abragam A, Goldman M. Principles of dynamic nuclear polarization. Rep Prog Phys. 1978;41:396–467.Google Scholar
  149. 149.
    Kohler SJ, Yen Y, Wolber J, Chen AP, Albers MJ, Bok R, Zhang V, Tropp J, Nelson S, Vigneron DB, Kurhanewicz J, Hurd RE. In vivo 13 carbon metabolic imaging at 3 T with hyperpolarized 13C-1-pyruvate. Magn Reson Med. 2007;58(1):65–9.PubMedGoogle Scholar
  150. 150.
    Chen AP, Cunningham CH, Ozturk-Isik E, Xu D, Hurd RE, Kelley DA, Pauly JM, Kurhanewicz J, Nelson SJ, Vigneron DB. High-speed 3 T MR spectroscopic imaging of prostate with flyback echo-planar encoding. J Magn Reson Imaging. 2007;25(6):1288–92.PubMedGoogle Scholar
  151. 151.
    Merritt ME, Harrison C, Storey C, Jeffrey FM, Sherry AD, Malloy CR. Hyperpolarized 13C allows a direct measure of flux through a single enzyme-catalyzed step by NMR. Proc Natl Acad Sci U S A. 2007;104(50):19773–7.PubMedCentralPubMedGoogle Scholar
  152. 152.
    Overhauser AW. Polarization of nuclei in metals. Phys Rev. 1953;92(2):411–5.Google Scholar
  153. 153.
    Abragam A. Overhauser effect in nonmetals. Phys Rev. 1955;98(6):1729–35.Google Scholar
  154. 154.
    Boer WD, Borghini M, Morimoto K, Niinikoski TO, Udo F. Dynamic polarization of protons, deuterons, and carbon-13 nuclei: thermal contact between nuclear spins and an electron spin-spin interaction resevoir. J Low Temp Phys. 1974;15:249–67.Google Scholar
  155. 155.
    Keshari KR, Kurhanewicz J, Wilson DM, Jeffries RE, Dewar BJ, Van Criekinge M, et al. Hyperpolarized 13C spectroscopy and a novel NMR-compatible bioreactor system for the investigation of real time cellular metabolism. Magn Reson Med. 2010;63:322–9.PubMedCentralPubMedGoogle Scholar
  156. 156.
    Chen AP, Albers MJ, Cunningham CH, Kohler SJ, Yen YF, Hurd RE, Tropp J, Bok R, Pauly JM, Nelson SJ, Kurhanewicz J, Vigneron DB. Hyperpolarized C-13 spectroscopic imaging of the TRAMP mouse at 3 T-initial experience. Magn Reson Med. 2007;58(6):1099–106.PubMedGoogle Scholar
  157. 157.
    Frydman L, Blazina D. Ultrafast two-dimensional nuclear magnetic resonance spectroscopy of hyperpolarized solutions. Nat Phys. 2007;3:415–9.Google Scholar
  158. 158.
    Merritt ME, Harrison C, Mander W, Malloy CR, Sherry AD. Dipolar cross-relaxation modulates signal amplitudes in the (1)H NMR spectrum of hyperpolarized [(13)C]formate. J Magn Reson. 2007;189(2):280–5.PubMedCentralPubMedGoogle Scholar
  159. 159.
    Reeder SB, Brittain JH, Grist TM, Yen YF. Least-squares chemical shift separation for (13)C metabolic imaging. J Magn Reson Imaging. 2007;26(4):1145–52.PubMedGoogle Scholar
  160. 160.
    Levin YS, Mayer D, Yen YF, Hurd RE, Spielman DM. Optimization of fast spiral chemical shift imaging using least squares reconstruction: application for hyperpolarized (13)C metabolic imaging. Magn Reson Med. 2007;58(2):245–52.PubMedGoogle Scholar
  161. 161.
    Macdonald J, Kurhanewicz J, Dahiya R, Espanol MT, Chang LH, Goldberg B, James TL, Narayan P. Effect of glucose and confluency on phosphorus metabolites of perfused human prostatic adenocarcinoma cells as determined by 31P MRS. Magn Reson Med. 1993;29(2):244–8.PubMedGoogle Scholar
  162. 162.
    Zierhut ML, Yen YF, Chen AP, Bok R, Albers MJ, Zhang V, et al. Kinetic modeling of hyperpolarized (13)C(1)-pyruvate metabolism in normal rats and TRAMP mice. J Magn Reson. 2010;202:85–92.PubMedCentralPubMedGoogle Scholar
  163. 163.
    Lapidot A, Gopher A. Cerebral metabolic compartmentation. Estimation of glucose flux via pyruvate carboxylase/pyruvate dehydrogenase by 13C nmr isotopomer analysis of D-[U-13C] glucose metabolites. J Biol Chem. 1994;269:27198–208.PubMedGoogle Scholar
  164. 164.
    Lown KS, Thummel KE, Benedict PE, Shen DD, Turgeon DK, Berent S, Watkins PB. The erythromycin breath test predicts clearance of midazolam. Clin Pharmacol Ther. 1995;57:16–24.PubMedGoogle Scholar
  165. 165.
    Kronbach T, Mathys D, Umeno M, Gonzalez FJ, Meyer UA. Oxidation of midazolam and trizaolam by human liver cytochrome P450IIIA4. Mol Pharmacol. 1989;36:89–96.PubMedGoogle Scholar
  166. 166.
    Bork RW, Muto T, Beaune PH, Srivastava PK, Lloyd RS, Guengerich FP. Characterization of mRNA species related to human liver cytochrome P-450 nifedipine oxidase and the regulation of catalytic activity. J Biol Chem. 1989;264:910–9.PubMedGoogle Scholar
  167. 167.
    Watkins PB, Murray SA, Winkelman LG, Heuman DM, Wrighton SA, Guzelian PS. Erythromycin breath test as an assay of glucocorticoid-inducibleliver cytochrome P-450. J Clin Invest. 1989;83:688–97.PubMedCentralPubMedGoogle Scholar
  168. 168.
    Baker AL, Kotake AN, Schoeller DS. Clinical utility of breath tests for the assessment of hepatic function. Semin Liver Dis. 1983;3:318–29.PubMedGoogle Scholar
  169. 169.
    Keshari KR, Kurhanewicz J, Wilson DM, Jeffries RE, Dewar BJ, Van Criekinge M, Vigneron DB, Macdonald JM. Hyperpolarized 13C spectroscopy and a novel NMR-compatible bioreactor system for the investigation of real time cellular metabolism. Magn Reson Med. 2010;63:322–9.PubMedCentralPubMedGoogle Scholar
  170. 170.
    Kuramitsu S, Inoue K, Kondo K, Aki K, Kagamiyama H. Aspartate aminotransferase isozymes from rabbit liver. Purification and properties. J Biochem. 1985;97(5):1337–45.PubMedGoogle Scholar
  171. 171.
    Cunningham CH, Chen AP, Lustig M, Hargreaves BA, Lupo J, Xu D, et al. Pulse sequence for dynamic volumetric imaging of hyperpolarized metabolic products. J Magn Reson. 2008;193(1):139–46.PubMedCentralPubMedGoogle Scholar
  172. 172.
    Jin ES, Jones JG, Merritt M, Burgess SC, Malloy CR, Sherry AD. Glucose production, gluconeogenesis, and hepatic tricarboxylic acid cycle fluxes measured by nuclear magnetic resonance analysis of a single glucose derivative. Anal Biochem. 2004;327(2):149–55.PubMedGoogle Scholar
  173. 173.
    Jue T, Rothman DL, Tavitian BA, Shulman RG. Natural-abundance 13C NMR study of glycogen repletion in human liver and muscle. Proc Natl Acad Sci U S A. 1989;86(5):1439–42.PubMedCentralPubMedGoogle Scholar
  174. 174.
    Knüttel A, Kimmich R, Spohn KH. Motion-insensitive volume-selective pulse sequences for direct and proton-detected 13C spectroscopy: detection of glycogen in the human liver in vivo. Magn Reson Med. 1991;17(2):470–82.PubMedGoogle Scholar
  175. 175.
    Magnusson I, Rothman DL, Jucker B, Cline GW, Shulman RG, Shulman GI. Liver-glycogen turnover in fed and fasted humans. Am J Physiol. 1994;266:E796–803.PubMedGoogle Scholar
  176. 176.
    Jehenson P, Canioni P, Hantraye P, Syrota A. Carbon 13 NMR study of glycogen metabolism in the baboon liver in vivo. Biochem Biophys Res Commun. 1992;182(2):900–5.PubMedGoogle Scholar
  177. 177.
    Alger JR, Shulman RG. Metabolic applications of high-resolution 13C nuclear magnetic resonance spectroscopy. Br Med Bull. 1984;40(2):160–4.PubMedGoogle Scholar
  178. 178.
    Vogt JA, Yarmush DM, Yu YM, Zupke C, Fischman AJ, Tompkins RG, et al. TCA cycle flux estimates from NMR- and GC-MS-determined [13C]glutamate isotopomers in liver. Am J Physiol. 1997;272(6 Pt 1):C2049–62.PubMedGoogle Scholar
  179. 179.
    Canioni P, Alger JR, Shulman RG. Natural abundance Carbon-13 nuclear magnetic resonance spectroscopy of liver and adipose tissue of the living rat. Biochemistry. 1983;22(21):4974–80.PubMedGoogle Scholar
  180. 180.
    Cross TA, Pahl C, Oberhänsli R, Aue WP, Keller U, Seelig J. Ketogenesis in the living rat followed by 13C NMR spectroscopy. Biochemistry. 1984;23(26):6398–402.PubMedGoogle Scholar
  181. 181.
    Desmoulin F, Canioni P, Cozzone PJ. Glutamate-glutamine metabolism in the perfused rat liver 13C-NMR study using (2-13C)-enriched acetate. FEBS Lett. 1985;185(1):29–32.PubMedGoogle Scholar
  182. 182.
    Stromski ME, Arias-Mendoza F, Alger JR, Shulman RG. Hepatic gluconeogenesis from alanine: 13C nuclear magnetic resonance methodology for in vivo studies. Magn Reson Med. 1986;3(1):24–32.PubMedGoogle Scholar
  183. 183.
    Kalderon B, Gopher A, Lapidot A. Metabolic pathways leading to liver glycogen repletion in vivo, studied by GC-MS and NMR. FEBS Lett. 1986;204(1):29–32.PubMedGoogle Scholar
  184. 184.
    Shulman GI, Rossetti L, Rothman DL, Blair JB, Smith D. Quantitative analysis of glycogen repletion by nuclear magnetic resonance spectroscopy in the conscious rat. J Clin Invest. 1987;80(2):387–93.PubMedCentralPubMedGoogle Scholar
  185. 185.
    Kalderon B, Gopher A, Lapidot A. A quantitative analysis of the metabolic pathways of hepatic glucose synthesis in vivo with 13C-labeled substrates. FEBS Lett. 1987;213(1):209–14.PubMedGoogle Scholar
  186. 186.
    Künnecke B, Cerdan S. Multilabeled 13C substrates as probes in in vivo 13C and 1H NMR spectroscopy. NMR Biomed. 1989;2(5–6):274–7.PubMedGoogle Scholar
  187. 187.
    Shalwitz RA, Reo NV, Becker NN, Hill AC, Ewy CS, Ackerman JJ. Hepatic glycogen synthesis from duodenal glucose and alanine. An in situ 13C NMR study. J Biol Chem. 1989;264(7):3930–4.PubMedGoogle Scholar
  188. 188.
    Chen W, Ackerman JJ. Localized 13C-[1H] NMR of rat liver in vivo using surface-spoiling gradients. NMR Biomed. 1989;2(5–6):267–73.PubMedGoogle Scholar
  189. 189.
    Zang LH, Laughlin MR, Rothman DL, Shulman RG. 13C NMR relaxation times of hepatic glycogen in vitro and in vivo. Biochemistry. 1990;29(29):6815–20.PubMedGoogle Scholar
  190. 190.
    Cunnane SC. Carbon-by-carbon discrimination of 13C incorporation into liver fatty acids. FEBS Lett. 1992;306(2–3):273–5.PubMedGoogle Scholar
  191. 191.
    Van Cauteren M, Miot F, Segebarth CM, Eisendrath H, Osteaux M, Willem R. Excitation characteristics of adiabatic half-passage RF pulses used in surface coil MR spectroscopy. Application to 13C detection of glycogen in the rat liver. Phys Med Biol. 1992;37(5):1055–64.PubMedGoogle Scholar
  192. 192.
    Wehmeyer N, Gunderson H, Nauman J, Savage S, Hartzell C. Determination of the glycogen synthesis pathway by 13C nuclear magnetic resonance analysis. Metabolism. 1994;43(1):38–43.PubMedGoogle Scholar
  193. 193.
    Jones JG, Cottam GL, Miller BC, Sherry AD, Malloy CR. A method for obtaining 13C isotopomer populations in 13C-enriched glucose. Anal Biochem. 1994;217(1):148–52.PubMedGoogle Scholar
  194. 194.
    Jucker BM, Lee JY, Shulman RG. In vivo 13C NMR measurements of hepatocellular tricarboxylic acid cycle flux. J Biol Chem. 1998;273(20):12187–94.PubMedGoogle Scholar
  195. 195.
    Küstermann E, Seelig J, Künnecke B. Ascorbic acid, a vitamin, is observed by in vivo 13C nuclear magnetic resonance spectroscopy of rat liver. Am J Physiol. 1998;274(1 Pt 1):E65–71.PubMedGoogle Scholar
  196. 196.
    Likhodii SS, Cunnane SC. Uptake of 13C-tracer arachidonate and gamma-linolenate by the brain and liver of the suckling rat observed using 13C-NMR. J Neurochem. 1998;72(6):2548–55.Google Scholar
  197. 197.
    Beckmann N, Seelig J, Wick H. Analysis of glycogen storage disease by in vivo 13C NMR: comparison of normal volunteers with a patient. Magn Reson Med. 1990;16(1):150–60.PubMedGoogle Scholar
  198. 198.
    Petersen KF, West AB, Reuben A, Rothman DL, Shulman GI. Noninvasive assessment of hepatic triglyceride content in humans with 13C nuclear magnetic resonance spectroscopy. Hepatology. 1996;24(1):114–7.PubMedGoogle Scholar
  199. 199.
    Roden M, Perseghin G, Petersen KF, Hwang JH, Cline GW, Gerow K, et al. The roles of insulin and glucagon in the regulation of hepatic glycogen synthesis and turnover in humans. J Clin Invest. 1996;97:642–8.PubMedCentralPubMedGoogle Scholar
  200. 200.
    Stevens AN, Iles RA, Morris PG, Griffiths JR. Detection of glycogen in a glycogen storage disease by 13C nuclear magnetic resonance. FEBS Lett. 1982;150(2):489–93.PubMedGoogle Scholar
  201. 201.
    Sillerud LO, Shulman RG. Structure and metabolism of mammalian liver glycogen monitored by carbon-13 nuclear magnetic resonance. Biochemistry. 1983;22(5):1087–94.PubMedGoogle Scholar
  202. 202.
    Reo NV, Siegfried BA, Ackerman JJ. Direct observation of glycogenesis and glucagon-stimulated glycogenolysis in the rat liver in vivo by high-field carbon-13 surface coil NMR. J Biol Chem. 1984;259(22):13664–7.PubMedGoogle Scholar
  203. 203.
    Siegfried BA, Reo NV, Ewy CS, Shalwitz RA, Ackerman JJ, McDonald JM. Effects of hormone and glucose administration on hepatic glucose and glycogen metabolism in vivo. A 13C NMR study. J Biol Chem. 1985;260(30):16137–42.PubMedGoogle Scholar
  204. 204.
    Pahl-Wostl C, Seelig J. Metabolic pathways for ketone body production. 13C NMR spectroscopy of rat liver in vivo using 13C-multilabeled fatty acids. Biochemistry. 1986;25(22):6799–807.PubMedGoogle Scholar
  205. 205.
    Pahl-Wostl C, Seelig J. Ketogenesis in the living rat followed by 13C-NMR spectroscopy. Infusion of [1,3-13C]octanoate. Biol Chem Hoppe Seyler. 1987;368(3):205–14.PubMedGoogle Scholar
  206. 206.
    Cohen SM. Effects of insulin on perfused liver from streptozotocin-diabetic and untreated rats: 13C NMR assay of pyruvate kinase flux. Biochemistry. 1987a;26(2):573–80.PubMedGoogle Scholar
  207. 207.
    Cohen SM. 13C NMR study of effects of fasting and diabetes on the metabolism of pyruvate in the tricarboxylic acid cycle and the utilization of pyruvate and ethanol in lipogenesis in perfused rat liver. Biochemistry. 1987b;26(2):581–9.PubMedGoogle Scholar
  208. 208.
    Shulman GI, Rothman DL, Chung Y, Rossetti L, Petit Jr WA, Barrett EJ, et al. 13C NMR studies of glycogen turnover in the perfused rat liver. J Biol Chem. 1988;263(11):5027–9.PubMedGoogle Scholar
  209. 209.
    Cerdan S, Künnecke B, Dölle A, Seelig J. In situ metabolism of 1, omega medium chain dicarboxylic acids in the liver of intact rats as detected by 13C and 1H NMR. J Biol Chem. 1988;263(24):11664–74.PubMedGoogle Scholar
  210. 210.
    Liu KJ, Henderson TO, Kleps RA, Reyes MC, Nyhus LM. Gluconeogenesis in the liver of tumor rats. J Surg Res. 1990;49(2):179–85.PubMedGoogle Scholar
  211. 211.
    David M, Petit WA, Laughlin MR, Shulman RG, King JE, Barrett EJ. Simultaneous synthesis and degradation of rat liver glycogen. An in vivo nuclear magnetic resonance spectroscopic study. J Clin Invest. 1991;86(2):612–7.Google Scholar
  212. 212.
    Künnecke B, Seelig J. Glycogen metabolism as detected by in vivo and in vitro 13C-NMR spectroscopy using [1,2-13C2]glucose as substrate. Biochim Biophys Acta. 1991;1095(2):103–13.PubMedGoogle Scholar
  213. 213.
    Liu KJ, Kleps R, Henderson T, Nyhus L. 13C NMR study of hepatic pyruvate carboxylase activity in tumor rats. Biochem Biophys Res Commun. 1991;179(1):366–71.PubMedGoogle Scholar
  214. 214.
    Shulman GI, DeFronzo RA, Rossetti L. Differential effect of hyperglycemia and hyperinsulinemia on pathways of hepatic glycogen repletion. Am J Physiol. 1991;260(5 Pt 1):E731–5.PubMedGoogle Scholar
  215. 215.
    Muller HJ, Lanens D, de Cock Buning TJ, van de Vyver FL, Alderweireldt FC, Dommisse R, et al. Noninvasive in vivo 13C-NMR spectroscopy in the rat to study the pharmacokinetics of 13C-labeled xenobiotics. Drug Metab Dispos. 1992;20(4):507–9.PubMedGoogle Scholar
  216. 216.
    Lanens D, Muller HJ, Van de Vyver F, de Cock-Bunning T, Spanoghe M, Van der Linden A, et al. Noninvasive in vivo 13C-NMR spectroscopy of a 13C-labeled xenobiotic in the rat. Magn Reson Imaging. 1992;10(6):975–81.PubMedGoogle Scholar
  217. 217.
    Petersen KF, Blair JB, Shulman GI. Triiodothyronine treatment increases substrate cycling between pyruvate carboxylase and malic enzyme in perfused rat liver. Metabolism. 1995;44(11):1380–3.PubMedGoogle Scholar
  218. 218.
    Morikawa S, Inubushi T, Takahashi K, Terada Y, Iwata S, Ozawa K. Glucose and energy metabolism in rat liver after ischemic damage assessed by 13 C and 31 P NMR spectroscopy. J Surg Res. 1996;63(2):393–9.PubMedGoogle Scholar
  219. 219.
    Morikawa S, Inubushi T, Takahashi K, Ishii H, Ozawa K. Gluconeogenesis and phosphoenergetics in rat liver during endotoxemia. J Surg Res. 1998;74(2):179–86.PubMedGoogle Scholar
  220. 220.
    Changani KK, Bell JD, Iles RA. 13C-Glycogen deposition during pregnancy in the rat following routine meal feeding. Biochim Biophys Acta. 1998;1380(2):198–208.PubMedGoogle Scholar
  221. 221.
    Yarmush DM, MacDonald AD, Foy BD, Berthiaume F, Tompkins RG, Yarmush ML. Cutaneous burn injury alters relative tricarboxylic acid cycle fluxes in rat liver. J Burn Care Rehabil. 1999;20(4):292–302.PubMedGoogle Scholar
  222. 222.
    Zhaofan X, Jianguang T, Guangyi W, Hongtai T, Shengde G, Horton JW. Effect of thermal injury on relative anaplerosis and gluconeogenesis in the rat during infusion of [U-13C] propionate. Burns. 2002;28(7):625–30.PubMedGoogle Scholar
  223. 223.
    Baillet-Blanco L, Beauvieux MC, Gin H, Rigalleau V, Gallis JL. Insulin induces a positive relationship between the rates of ATP and glycogen changes in isolated rat liver in presence of glucose; a 31P and 13C NMR study. Nutr Metab (Lond). 2005;2:32.Google Scholar
  224. 224.
    Geoffrion Y, Butler K, Pass M, Smith IC, Deslauriers R. Plasmodium berghei: gluconeogenesis in the infected mouse liver studied by 13C nuclear magnetic resonance. Exp Parasitol. 1988;59(3):364–74.Google Scholar
  225. 225.
    Hall JE, Mackenzie NE, Mansfield JM, McCloskey DE, Scott AI. 13C-NMR analysis of alanine metabolism by isolated perfused livers from C3HeB/FeJ mice infected with African trypanosomes. Comp Biochem Physiol B. 1988;89(4):679–85.PubMedGoogle Scholar
  226. 226.
    Nedelec JF, Mégnin F, Patry J, Jullien P, Lhoste JM, Dimicoli JL. Modification of the gluconeogenic/glycolytic balance in isolated perfused liver of myeloproliferative leukemia infected mice: a 13C NMR study. Comp Biochem Physiol B. 1990;95(3):505–14.PubMedGoogle Scholar
  227. 227.
    Cohen SM, Werrmann JG, Tota MR. 13C NMR study of the effects of leptin treatment on kinetics of hepatic intermediary metabolism. Proc Natl Acad Sci U S A. 1998;95(13):7385–90.PubMedCentralPubMedGoogle Scholar
  228. 228.
    Choi IY, Wu C, Okar DA, Lange AJ, Gruetter R. Elucidation of the role of fructose 2,6-bisphosphate in the regulation of glucose fluxes in mice using in vivo (13)C NMR measurements of hepatic carbohydrate metabolism. Eur J Biochem. 2002;269(18):4418–26.PubMedGoogle Scholar
  229. 229.
    Cohen SM, Duffy JL, Miller C, Kirk BA, Candelore MR, Ding VD, et al. Direct observation (NMR) of the efficacy of glucagon receptor antagonists in murine liver expressing the human glucagon receptor. Bioorg Med Chem. 2006;14(5):1506–17.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2012

Authors and Affiliations

  • Justyna Wolak
    • 1
  • Kayvan Rahimi-Keshari
    • 1
  • Rex E. Jeffries
    • 1
  • Maliackal Poulo Joy
    • 2
  • Abigail Todd
    • 2
  • Peter Pediatitakis
    • 1
  • Brian J. Dewar
    • 2
  • Jason H. Winnike
    • 1
  • Oleg Favorov
    • 1
  • Timothy C. Elston
    • 2
  • Lee M. Graves
    • 2
  • John Kurhanewicz
    • 3
  • Daniel Vigneron
    • 3
  • Ekhson Holmuhamedov
    • 4
  • Jeffrey M. Macdonald
    • 1
    Email author
  1. 1.Department of Biomedical EngineeringUniversity of North Carolina School of MedicineChapel HillUSA
  2. 2.Department of PharmacologyUniversity of North Carolina School of MedicineChapel HillUSA
  3. 3.Departments of Radiology and Pharmaceutical ChemistryUniversity of California at San FranciscoSan FranciscoUSA
  4. 4.Department of Cell and Molecular BiologyUniversity of North Carolina School of MedicineChapel HillUSA

Personalised recommendations